Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.
Nat Cancer. 2022 Oct;3(10):1151-1164. doi: 10.1038/s43018-022-00416-8. Epub 2022 Aug 29.
Nat Cancer. 2022.
PMID: 36038778
Free PMC article.
Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.
Kezlarian B, Montecalvo J, Bodd FM, Chang JC, Riedel E, White C, Rekhtman N, Sauter JL.
Kezlarian B, et al. Among authors: bodd fm.
Cancer Cytopathol. 2023 Aug;131(8):526-534. doi: 10.1002/cncy.22709. Epub 2023 Jun 6.
Cancer Cytopathol. 2023.
PMID: 37278102
Item in Clipboard
Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.
Febres-Aldana CA, Chang JC, Jungbluth AA, Adusumilli PS, Bodd FM, Frosina D, Geronimo JA, Hernandez E, Irawan H, Offin MD, Rekhtman N, Travis WD, Vanderbilt C, Zauderer MG, Zhang Y, Ladanyi M, Yang SR, Sauter JL.
Febres-Aldana CA, et al. Among authors: bodd fm.
Mod Pathol. 2024 Mar;37(3):100420. doi: 10.1016/j.modpat.2023.100420. Epub 2024 Jan 5.
Mod Pathol. 2024.
PMID: 38185249
Free article.
Item in Clipboard
Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma.
Li Y, Yang SR, Chen YB, Adusumilli PS, Bialik A, Bodd FM, Ladanyi M, Lopardo J, Offin MD, Rusch VW, Travis WD, Zauderer MG, Chang JC, Sauter JL.
Li Y, et al. Among authors: bodd fm.
Mod Pathol. 2023 Mar;36(3):100030. doi: 10.1016/j.modpat.2022.100030. Epub 2023 Jan 10.
Mod Pathol. 2023.
PMID: 36788094
Free PMC article.
Item in Clipboard
Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
Chang JC, Alex D, Bott M, Tan KS, Seshan V, Golden A, Sauter JL, Buonocore DJ, Vanderbilt CM, Gupta S, Desmeules P, Bodd FM, Riely GJ, Rusch VW, Jones DR, Arcila ME, Travis WD, Ladanyi M, Rekhtman N.
Chang JC, et al. Among authors: bodd fm.
Clin Cancer Res. 2019 Dec 1;25(23):7113-7125. doi: 10.1158/1078-0432.CCR-19-1700. Epub 2019 Aug 30.
Clin Cancer Res. 2019.
PMID: 31471310
Free PMC article.
Item in Clipboard
Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.
Li Y, Salama AM, Baine MK, Bodd FM, Offin MD, Rekhtman N, Zauderer MG, Travis WD, Adusumilli PS, Sauter JL.
Li Y, et al. Among authors: bodd fm.
Cancer Cytopathol. 2023 Aug;131(8):495-506. doi: 10.1002/cncy.22705. Epub 2023 May 1.
Cancer Cytopathol. 2023.
PMID: 37127928
Item in Clipboard
Cite
Cite